Skip to Main Content
Pharmacist's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Opioid Resources
    • Transitions of Care Resources
    • Journal Club
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Guide to Cannabis training for pharmacists that offers 16 hours of ACPE-accredited training based on the latest, science-based cannabis research. Only $199. Learn More!
  1. Home
  2. Browse
  3. Cardiology
  4. Ischemic Heart Disease/Acute Coronary Syndromes
  5. Treatment
  6. Clopidogrel (Plavix)

Clopidogrel (Plavix)

  • Angina (16)
  • Antithrombotics (413)
  • Arrhythmias (183)
  • Blood Pressure (35)
  • Cardiovascular Disease and Depression (10)
  • Cholesterol (59)
  • Dyslipidemia (316)
  • Endocarditis (21)
  • Heart Disease (96)
  • Heart Failure (216)
  • Hypertension (349)
  • Hypotension (23)
  • Ischemic Heart Disease/Acute Coronary Syndromes (404)
    • Cardiovascular Markers (34)
    • Drug-Induced Ischemic Heart Disease (43)
    • Guidelines (4)
    • Prevention (94)
    • Treatment (307)
      • ACEIs (67)
      • Anticoagulants (35)
      • ARBs (62)
      • ARNIs (8)
      • Aspirin (91)
      • Beta-Blockers (85)
      • Calcium Channel Blockers (28)
      • Cangrelor (Kengreal) (2)
      • Clopidogrel (Plavix) (54)
      • Natural Medicines/Supplements (7)
      • Nitrates (19)
      • Prasugrel (Effient) (28)
      • Statins (57)
  • Myocardial Infarction (53)
  • Peripheral Vascular Disease (9)
  • Pulmonary Arterial Hypertension (1)
  • Raynaud's (1)
  • Resources (1030)
  • Stroke (192)
46 - 54 of 54 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Guideline: Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use December 2008
Article: Clopidogrel (Plavix) will compete with prasugrel (Effient) April 2008
Commentary: Drug Eluting Stents and Antiplatelet Medications February 2007
Guideline: ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention February 2007
Guideline: 2007 Science Advisory on Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients with Coronary Artery Stents February 2007
Guideline: 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention February 2007
Commentary: New Antithrombotic and Thrombolytic Guidelines June 2005
Guideline: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines June 2005
Article: New guidelines from the American College of Chest Physicians will change the use of antithrombotic drugs for certain conditions. June 2005
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved